Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for refractory complex regional pain syndrome
ISRCTN12908996Phase 2Completed
- Sponsor
- University of Liverpool
- Start
- Nov 2021
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 2, open-label, single-arm trial of anakinra in complex regional pain syndrome (CRPS), sponsored by University of Liverpool. Primary endpoints: Safety of anakinra, Tolerance of anakinra and 2 more. Started Nov 2021; status: completed.
02
Drugs
anakinra
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on ISRCTN12908996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12908996.